tiprankstipranks

IT:SELJLB ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
14Bullish
1Neutral
7Bearish
Oscillators
Sell
4Bullish
1Neutral
5Bearish
Moving Averages
Strong Buy
10Bullish
0Neutral
2Bearish
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) Moving Averages Convergence Divergence (MACD) indicator is 0.95, suggesting Selectra Investments SICAV - J. Lamarck Biotech is a Sell.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) 20-Day exponential moving average is 106.76, making it a Buy.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) 50-Day exponential moving average is 106.59, making it a Buy.

Selectra Investments SICAV - J. Lamarck Biotech (SELJLB) Pivot Points

Feb 22, 2025, 04:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
109.48
109.48
109.48
109.48
109.48
109.48
109.48
Fibonacci
109.48
109.48
109.48
109.48
109.48
109.48
109.48

Selectra Investments SICAV - J. Lamarck Biotech (SELJLB) Moving Averages

Feb 22, 2025, 04:53 PM
Period
Simple
Exponential
MA5
108.86Buy
108.79Buy
MA10
107.07Buy
107.75Buy
MA20
106.24Buy
106.76Buy
MA50
105.65Buy
106.59Buy
MA100
107.95Buy
107.72Buy
MA200
109.61Sell
109.55Sell
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) 10-Day exponential moving average is 107.75, making it a Buy.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) 100-Day exponential moving average is 107.72, making it a Buy.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) 50-day simple moving average is 105.65, creating a Buy signal.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) 100-day simple moving average is 107.95, creating a Buy signal.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) 200-day simple moving average is 109.61, creating a Sell signal.

Selectra Investments SICAV - J. Lamarck Biotech (SELJLB) Technical Analysis

Feb 22, 2025, 04:53 PM
Name
Value
Action
RSI (14)
60.09
Neutral
STOCH (9,6)
91.89
Sell
STOCHRSI (14)
91.89
Sell
MACD (12,26)
0.95
Sell
ADX (14)
11.07
Buy
Williams %R
-12.17
Sell
CCI (14)
147.40
Sell
ATR (14)
1.14
-
Ultimate Oscillator
76.45
Buy
ROC
4.45
Buy
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) Relative Strength Index (RSI) is 60.09, creating a Neutral signal.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) Trend Strength Indicator (ADX) is 11.07, creating a Buy signal.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) Commodity Channel Index (CCI) is 147.40, creating a Sell signal.
Selectra Investments SICAV - J. Lamarck Biotech’s (SELJLB) Price Rate of Change (ROC) is 4.45, creating a Buy signal.

FAQ

Is SELJLB a Buy, Hold, or Sell?
Based on SELJLB’s technical indicators, SELJLB is a Buy.
    What is SELJLB’s RSI (14)?
    SELJLB’s RSI (14) is 60.09, which suggests SELJLB is a Neutral.
      What is SELJLB’s MACD?
      SELJLB’s MACD is 0.95, which suggests SELJLB is a Sell.
        What is SELJLB’s 5-day moving average?
        SELJLB’s 5-day moving average is 108.86, which suggests SELJLB is a Buy.
          What is SELJLB’s 20-day moving average?
          SELJLB 20-day moving average is 106.24, which suggests SELJLB is a Buy.
            What is SELJLB’s 50-day moving average?
            SELJLB’s 50-day moving average is 105.65, which suggests SELJLB is a Buy.
              What is SELJLB’s 200-day moving average?
              SELJLB’s 200-day moving average is 109.61, which suggests SELJLB is a Sell.
                What is SELJLB’s Williams % R (14)?
                SELJLB’s Williams % R (14) is -12.17, which suggests SELJLB is a Sell.
                  What is SELJLB’s CCI (14)?
                  SELJLB’s CCI (14) is 147.40, which suggests SELJLB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis